opioids

Oklahoma's trial is the first in a wave of litigation attempting to bring claims against opioid manufacturers. The state is seeking millions of dollars in damages and penalties.

A study looked at who gets prescriptions for buprenorphine, and found that white patients are almost 35 times as likely to get the lifesaving addiction treatment than African Americans.

After dozens of health care workers were charged with illegally prescribing opioids in Appalachia, local health agencies are trying to make sure chronic pain patients don't fall through the cracks.

A Philadelphia group hopes to open a site for people to use drugs under medical supervision. Faced with legal challenges, the group is making a moral and religious case for its proposed facility.

To reduce opioid overdose deaths, North Carolina lawmakers want to crack down on the people who distribute them.

The 10-week trial of five executives from Insys Therapeutics wrapped up in Boston on Friday. The executives are accused of bribing doctors and deceiving insurance companies to boost opioid sales.

Overdose deaths involving fentanyl are rising — up 113 percent on average each year from 2013 to 2016. Dealers are adding cheap fentanyl to the illicit drug supply, and some users get it accidentally.

Once a tiny specialty that drew mostly psychiatrists, addiction medicine is expanding its accredited training to include residents from specialties like family medicine who see it as a calling.

Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies' reputations. Litigation has forced the release of internal documents that are shifting the narrative.